1 Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients[J]. Brain, 2000, 123(Pt 7): 1481-1494.
[2]
2 Lawn ND, Westmoreland BF, Kiely MJ, et al. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis[J]. Mayo Clin Proc, 2003, 78(11): 1363-1368.
[3]
3 Yuasa T, Fujita K. Limbic encephalitis--history, symptoms, and the latest classification[J]. Brain Nerve, 2010, 62(8): 817-826.
[4]
4 Bataller L, Kleopa KA, Wu GF, et al. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes[J]. J Neurol Neurosurg Psychiatry, 2007, 78(4): 381-385.
[5]
5 Troester F, Weske G, Schlaudraff E, et al. Image of the month. FDG-PET in paraneoplastic limbic encephalitis[J]. Eur J Nucl Med Mol Imaging, 2009, 36(3): 539.
[6]
6 Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes[J]. J Neurol Neurosurg Psychiatry, 2004, 75(8): 1135-1140.
[7]
7 Park S, Choi H, Cheon GJ, et al. 18F-FDG PET/CT in anti-LGI1 encephalitis: initial and follow-up findings[J]. Clin Nucl Med, 2015, 40(2): 156-158.
[8]
8 Spatola M, Stojanova V, Prior JO, et al. Serial brain 18FDG-PET in anti-AMPA receptor limbic encephalitis[J]. J Neuroimmunol, 2014, 271(1/2): 53-55.
[9]
9 Masangkay N, Basu S, Moghbel M, et al. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings[J]. Nucl Med Commun, 2014, 35(10): 1038-1046.
[10]
10 Younes-Mhenni S, Janier MF, Cinotti L, et al. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes[J]. Brain, 2004, 127(Pt 10): 2331-2338.
